Related Experiment Video

Updated: Jun 9, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Caspase-8 as a therapeutic target in cancer

Dwayne G Stupack1

  • 1Department of Pathology & the Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive MC0803, La Jolla, CA 92093-0803, USA. dstupack@ucsd.edu

Cancer Letters
|September 7, 2010
PubMed

Insights

Caspase-8 initiates cell death but also has non-apoptotic functions. Its role in cancer varies, requiring careful, case-by-case evaluation for therapeutic strategies targeting caspase-8.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Caspase-8 is a key initiator of apoptosis via death receptor pathways.
  • Clinical interest focuses on modulating caspase-8 for cancer therapy.
  • Caspase-8 exhibits diverse non-apoptotic functions, including NF-κB signaling and autophagy regulation.

Purpose of the Study:

  • To explore the dual role of caspase-8 in tumor malignancy.
  • To investigate the heterogeneity of caspase-8 expression in various cancers.
  • To assess the implications of targeting caspase-8 expression therapeutically.

Main Methods:

  • Review of existing literature on caspase-8 functions.
  • Analysis of caspase-8 expression patterns across different tumor types.
  • Evaluation of therapeutic strategies aimed at caspase-8 modulation.

Main Results:

  • Caspase-8 can either promote or suppress tumor malignancy depending on cellular context.
  • Significant heterogeneity in caspase-8 expression is observed across diverse cancers.
  • Therapeutics increasing caspase-8 expression may not be universally beneficial.

Conclusions:

  • The role of caspase-8 in cancer is context-dependent and complex.
  • Targeting caspase-8 requires a nuanced, case-by-case approach.
  • Further research is needed to fully elucidate caspase-8's multifaceted roles in oncology.

More Related Videos

Quantification of Immunostained Caspase-9 in Retinal Tissue05:18

Quantification of Immunostained Caspase-9 in Retinal Tissue

Published on: July 25, 2022

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...